News and Document archive source
copyrighted material disclaimer at bottom of page
NewsMine cabal-elite w-administration bush-team rumsfeld Viewing Item | Rumsfeld made more than 5 million from bird flu Original Source Link: (May no longer be active) http://www.washtimes.com/upi/20060312-101805-3122r.htmhttp://www.washtimes.com/upi/20060312-101805-3122r.htm
Rumsfeld makes killing on bird flu drug Mar. 12, 2006 at 10:27PM
A published reported says Defense Secretary Donald Rumsfeld has made more than $5 million from Tamiflu, the drug being sought to treat bird flu. More than 60 countries have ordered large stocks of the antiviral medication to treat a possible pandemic of the deadly H5N1 strain of the disease. The London Independent said Rumsfeld made more than $5 million in capital gains in 2004 from selling shares in the Gilead Sciences, the California biotechnology company that developed the drug. Tamiflu is now made and sold by Roche, which pays Gilead a royalty on every tablet sold. Rumsfeld was on the board of Gilead from 1988 to 2001, and was its chairman from 1997. He left to join the Bush administration, the newspaper said. A disclosure report showed that he still had up to $25 million worth of shares at the end of 2004. In a statement to The Independent on Sunday the Pentagon said: "Secretary Rumsfeld has no relationship with Gilead Sciences Inc. beyond his investments in the company."
|
| Files Listed: 20 |
This site contains copyrighted material the use of which has not always been
specifically authorized by the copyright owner. We are making such material
available in our efforts to advance understanding of environmental, political,
human rights, economic, democracy, scientific, and social justice issues, etc.
We believe this constitutes a 'fair use' of any such copyrighted material as
provided for in section 107 of the US Copyright Law. In accordance with
Title 17 U.S.C. Section 107, the material on this site is distributed without
profit to those who have expressed a prior interest in receiving the included
information for research and educational purposes. For more information,
go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use
copyrighted material from this site for purpose of your own that go beyond
'fair use', you must obtain permission from the copyright owner.
|